Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 21, 2010

Premium

Aushon BioSystems last week named Johann de Bono, John Heymach, Gavin MacBeath, and Gordon Mills to its newly formed scientific advisory board.

De Bono is a consultant in medical oncology at the Royal Marsden Hospital and Institute of Cancer Research in London.

Heymach is an associate professor of thoracic head/neck medical oncology and cancer biology at the University of Texas MD Anderson Cancer Center, and he is director of the Thoracic Blood Biomarker Laboratory at the hospital.

MacBeath is senior director and head of translational research and co-founder at Merrimack Pharmaceuticals, and he was a faculty member in the department of chemistry and chemical biology at Harvard University.

Mills is university chair in cancer medicine, chair of the department of systems biology in the division of cancer medicine, and co-head of the Kleberg Center for Molecular Markers at MD Anderson.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.